What is fragile asthma?

Fragile asthma is a rare, serious form of asthma. Suffering suffers from the same symptoms that affect all asthmatics, including wheezing, coughing and breathing problems, but the symptoms are much harder, tending suddenly and unpredictably and are often resistant to traditional drugs. Type 1 fragile asthma 1 exists two varieties of fragile asthma, type 1 and 2. Patients are usually at high doses of daily drugs to control their asthma because regular doses are ineffective. The ongoing nature of their problem often limits their ability to perform normal everyday tasks, which is very difficult and frustrating with them. In addition to their chronic condition, they usually suffer from periodic serious attacks that appear almost without warning. These patients often require hospitalization to control their respiratory problems, either from an acute attack, or their overall condition deteriorates significantly over time. What distinguishes them from regular patients with asthma are unexpected, suddenOut attacks with extremely intense symptoms similar to those that affect the suffering type 1. These opportunities are often serious enough to be life -threatening and generally required hospitalization.

Treatment of fragile asthma usually involves the same drugs used for regular asthma, but often is much more needed than in normal cases. Fast bronchodilators are used for rapid relief and steroids, corticosteroids and bronchodilators with slow release are used for long -term control. Fragile asthma patients can use special delivery methods such as nebulizers or subcutaneous injections, to adapt larger doses of their doses. Patients of type 2 can also use strategies to try to limit their serious attacks such as avoiding allergens and other triggering.

Once the fragile asthmatic attack has progressed to the extent that it is necessary to be hospitalCAUTION must be treated quickly and aggressively because the condition is potentially fatal. Steroids and other medicines will often have to be administered intravenously to help control the symptoms. Patients who do not respond significantly to medicines may require the fan to obtain additional oxygen. Blood gases and oxygen should be monitored until they return to normal. The general condition of the patient should be evaluated to see if it can be safely released and managed by their asthma at home.